![Julia Gregory](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julia Gregory
Chairman at
NURIX THERAPEUTICS, INC.
Net worth: 473 492 $ as of 2026-05-30
Profile
Julia Paige Gregory is Chairman & Chief Executive Officer at Isometry Advisors, Inc. since 2016.
Chairman at Nurix Therapeutics, Inc. since 2024.
Director at Iconic Therapeutics, Inc. since 2017.
Managing Director at M.M.
Dillon & Co. LLC since 2018.
Director at Spur Therapeutics Ltd. and Spinal Simplicity LLC.
Independent Director at Biohaven Ltd. since 2022.
Formerly President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2009 to 2011.
President, Chief Executive Officer & Director at ContraFect Corp.
from 2015 to 2016.
Executive Chairman at Cavion, Inc. Director at Global Alliance for TB Drug Development from 2008 to 2014.
Director at Clinipace, Inc. from 2012 to 2014.
Independent Outside Director at Nxera Pharma Co., Ltd. from 2017 to 2020.
Non-Executive Director at Kuur Therapeutics Ltd. from 2018 to 2020.
Independent Director at IMV, Inc. from 2018 to 2023.
Independent Director at Biohaven Pharmaceutical Holding Co. Ltd. from 2017 to 2022.
Independent Non-Executive Director at Freeline Therapeutics Holdings Ltd. from 2020 to 2024.
CFO & Executive VP-Corporate Development at Lexicon Pharmaceuticals, Inc. from 2000 to 2008.
Head-Investment Banking & Life Sciences Practice at Punk Ziegel & Co. from 1996 to 2000.
Investment Banker at Dillon, Read & Co., Inc. from 1980 to 1996.
Education includes an MBA from The Wharton School of the University of Pennsylvania and undergraduate studies at Elliott School of International Affairs.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOHAVEN LTD. 0.02% | 2026-04-27 | 25,665 ( 0.02% ) | 282 572 $ | 2026-05-30 |
| 2026-05-14 | 10,750 ( 0.01% ) | 190 920 $ | 2026-05-30 |
Julia Gregory active positions
| Companies | Position | Start |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Chairman | 2024-05-19 |
| BIOHAVEN LTD. | Director/Board Member | 2022-09-27 |
Isometry Advisors, Inc.
 Isometry Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology financial and management advisory firm | Chief Executive Officer | 2016-03-31 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Director/Board Member | - |
M.M. Dillon & Co. LLC
 M.M. Dillon & Co. LLC Investment Banks/BrokersFinance Operates as an investment banking firm | Corporate Officer/Principal | 2018-05-31 |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Director/Board Member | 2017-03-31 |
Spinal Simplicity LLC
 Spinal Simplicity LLC Medical SpecialtiesHealth Technology Engages in design, development and production of orthopedic technologies | Director/Board Member | - |
Former positions of Julia Gregory
| Companies | Position | End |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Director/Board Member | 2024-02-19 |
| IMV INC. | Director/Board Member | 2023-01-07 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Julia Gregory
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Punk Ziegel & Co.
 Punk Ziegel & Co. Investment Banks/BrokersFinance Provides broker dealer services, investment banking and research services | Finance |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunoconjugate proteins intended to translate scientific insight into breakthrough medicines for serious diseases | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Develops tuberculosis drugs | Health Technology |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital contract research solutions | Commercial Services |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Spinal Simplicity LLC
Spinal Simplicity LLC Medical SpecialtiesHealth Technology Engages in design, development and production of orthopedic technologies | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Dillon, Read & Co., Inc.
 Dillon, Read & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
The Institute for the Study of Aging, Inc.
 The Institute for the Study of Aging, Inc. Services to the Health IndustryHealth Services The Institute for the Study of Aging, Inc. (ISOA) is a biomedical venture philanthropy that funds research projects to discover and develop new therapies for cognitive aging and Alzheimer's disease. Since 1998, ISOA has provided over $18 million in support to 80 research projects at academic institutions and biotechnology companies in seven countries. ISOA is a private foundation funded by the Estée Lauder Trust and recognized as a 501(c)(3) non-profit organization by the IRS. The company is based in New York, NY. | Health Services |
ContraFect Corp.
 ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops cell immunotherapies for treatment of solid and hematological malignancies | Health Technology |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
M.M. Dillon & Co. LLC
M.M. Dillon & Co. LLC Investment Banks/BrokersFinance Operates as an investment banking firm | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Elliott School of International Affairs
 Elliott School of International Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Health Technology |
Isometry Advisors, Inc.
Isometry Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology financial and management advisory firm | Commercial Services |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Julia Gregory
